Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Experimental Vaccine Against Cervical Cancer Said Promising
Agence France Presse;
Daly, Louise


A new study from GlaxoSmithKline reveals that, in preliminary tests, an experimental vaccine was 100 percent effective in protecting women against repeated infection by two strains of human papillomavirus. "The vaccine breaks new ground in the battle to prevent the spread of sexually transmitted diseases," said John Schiller of the National Cancer Institute. According to Schiller, the vaccine, which is administered in three doses, may be able to prevent as many as 75 percent of 500,000 cases of cervical cancer reported each year. If it receives all the necessary approvals, the vaccine could be on the market in three to five years.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.